Key result
A 38-year-old pregnant patient with severe bioprosthetic aortic valve failure was managed with a valve-in-valve transcatheter aortic valve replacement at 30 weeks' gestation.
Case Report (n=1)
This case demonstrates the feasibility of multidisciplinary cardio-obstetrics team management and valve-in-valve TAVR during pregnancy for severe bioprosthetic aortic valve failure.
May support valve replacement in select pregnant patients with bioprosthetic failure; leaves open need for prospective trials.
A 38-year-old pregnant patient was managed by the cardio-obstetrics multidisciplinary team for severe degenerative bioprosthetic aortic valve failure. She was medically managed utilizing echocardiogram and brain natriuretic peptide until she demonstrated worsening heart failure. A valve and cardio-obstetrics team evaluation led to valve-in-valve transcatheter aortic valve replacement at 30 weeks' gestation.
No takes yet. Share an insight, caveat, or question.
Bigelow et al. (2023) conducted a case report in Severe degenerative bioprosthetic aortic valve failure in pregnancy (n=1). Valve-in-valve transcatheter aortic valve replacement was evaluated. A 38-year-old pregnant patient with severe bioprosthetic aortic valve failure was managed with a valve-in-valve transcatheter aortic valve replacement at 30 weeks' gestation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: